ATRA vs AXP · rev $128.9M vs P/E 20, rev $41.30B
Atara Biotherapeutics Inc (ATRA) versus American Express Company (AXP) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
American Express Company (AXP) is a credit services company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported AXP revenue for 2025-12-31 was $41.30B. Net income was $10.83B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
ATRA currently screens at market cap $87.1M. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Not investment advice. Open the ATRA and AXP stock pages for the full models.
Not investment advice.